glp-1 agonist dementia Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease GLP-1 and Alzheimer's Disease: Research

Potential neuroprotective effects of BPC-157 are documented across preclinical models of brain injury, nerve damage, and neurotoxicity

Anti-inflammatory support

The subunit peptides (subunits VIII and X) and catalytic centers (cytochrome b , c 1 , and iron-sulfur protein) were not changed with aging in IFM [16]

However, certain groups, such as older adults and vegans, may require supplements to meet their needs

Turmeric and lemon act as antioxidants and bleaching agents to reduce the appearance of melasma spots naturally

However, once approved, physicians can legally prescribe drugs for off-label uses, as seen with Ozempic and other GLP-1 receptor agonists for weight loss